UK & Europe
Dutch Cabinet to Review Prevalence of Edibles in Coffeeshop Pilot
This article was written by Mauro Picavet and originally published on cannabisindustrie.nl.
Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
5,955stories
13 Novlast updated
More in Cannabis News
- Medical Cannabis
Bedrocan Could Be Revived Under New Entity as Dutch Minister Tells Parliament UK Supply Is ‘Under Investigation’
Bedrocan’s recent collapse, which has endangered the supply of life-saving epilepsy medicine for dozens of patients across Europe, could soon be revived under a new entity.
- Markets & Stocks
Cannabis Stocks Today — Thursday 12 November 2026: GrowGeneration sits at $1.26
Cannabis stocks sit slightly lower on Thursday morning, with the US market in pre-market trading and most quotes reflecting Wednesday’s close.
- Cannabis Daily News
Cannabis News Today — Wednesday, 11 November 2026: Statehouses Prepare Legalisation Bills as Governors Press Congress on Banking
A week after the US midterm elections, cannabis policy is moving from the ballot box to the statehouse and Capitol Hill.
- Prescribers & Clinics
Grow Group Completes £12m Recapitalisation and Restructuring, Appoints Co-CEOs and Completes Transition to Full Operations at its UK Manufacturing Facility
Grow Group has announced the completion of a recapitalisation, has appointed Co-CEOs, and now expects to generate healthy EBITDA in 2027.
- Industry Trends
What Does the Democratic Sweep Mean for US Cannabis?
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
- Interviews
Notes from a Scaling Healthcare Business: Governance First
In the first of a new three-part series, Graham Woodward, Chief Medical Officer at Releaf, sat down with Business of Cannabis to discuss what it takes to scale a medical cannabis clinic from three patients to tens of thousands in just two years.
- Medical Cannabis
‘We Hear About the Abuse, We Don’t See the Data’: German Cannabis Industry Challenges Berlin’s Case for Restrictions
Last week, the first Cannabis Health Symposium to take place in Germany saw the local industry’s leading telemedicine and pharmacy voices pull apart the rationale behind proposed medical cannabis restrictions.
- Pharmaceutical
Brains Bioceutical To List On NASDAQ Via SPAC At US$750m Valuation
Brains Bioceutical Corp. has announced plans to list on Nasdaq, in what would be the first US public-market debut for a UK-based cannabinoid pharma manufacturer since GW Pharmaceuticals was acquired by Jazz in 2021.
News by region
Legalisation by countryLicensing, patient access, taxation and retail models differ in every major market. Follow the regions and countries that matter to your business.
Europe
Germany, UK, Netherlands, Czech Republic, Switzerland, Spain, Portugal
- Germany cannabis news
- UK cannabis news
- Netherlands cannabis news
- UK & Europe regulation
- Legalisation by country
About Business of Cannabis
Business of Cannabis is the global B2B trade publication for the cannabis industry. We cover regulation, investment, market data and company news across Europe, North America and the wider global market.
Our readers include cannabis operators, investors, policymakers, healthcare professionals and advisers who need reliable, commercially focused reporting to make informed decisions. Business of Cannabis is published by Prohibition Partners, the cannabis industry's leading intelligence group.